CVS Health Backtesting

With this equity back-testing module your can estimate the performance of a buy and hold strategy of CVS Health Corporation and determine expected loss or profit from investing in CVS Health over given investment horizon. Check also CVS Health Hype Analysis, CVS Health Correlation, CVS Health Valuation, CVS Health Volatility as well as analyze CVS Health Alpha and Beta and CVS Health Performance
Investment Horizon     30 Days    Login   to change
X
Backtest

CVS Health 'What if' Analysis

February 27, 2017
 0.00 
No Change 0.00  0.0%
In 30 days
March 29, 2017
 0.00 
If you would invest  0.00  in CVS Health on February 27, 2017 and sell it all today you would earn a total of 0.00 from holding CVS Health Corporation or generate 0.0% return on investment in CVS Health over 30 days. CVS Health is related to or competes with MEDNAX, Laboratory Corp, Alere, HEALTHSOUTH Corp, HCA Holdings, and Concord Medical. It operates through Pharmacy Services and RetailLTC segments

CVS Health Upside/Downside Indicators

  

CVS Health Market Premium Indicators

CVS Health lagged returns against current returns

 Current and Lagged Values 
Benchmark  Embed    Timeline 

CVS Health regressed lagged prices vs. current prices

 Current vs Lagged Prices 
Benchmark  Embed    Timeline 

CVS Health Backtested Returns

Macroaxis considers CVS Health to be not too risky. CVS Health secures Sharpe Ratio (or Efficiency) of -0.4019 which signifies that CVS Health had -0.4019% of return per unit of volatility over the last 1 month. Macroaxis approach towards foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. CVS Health Corporation exposes twenty-eight different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm CVS Health Risk Adjusted Performance of (0.22) and Mean Deviation of 0.2833 to double-check risk estimate we provide. Macroaxis gives CVS Health performance score of 0 on a scale of 0 to 100. The firm shows Beta (market volatility) of 0.1579 which signifies that as returns on market increase, CVS Health returns are expected to increase less than the market. However during bear market, the loss on holding CVS Health will be expected to be smaller as well.. Even though it is essential to pay attention to CVS Health historical returns, it is always good to be careful when utilizing equity current trading patterns. Macroaxis approach towards foreseeing future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. CVS Health Corporation exposes twenty-eight different technical indicators which can help you to evaluate its performance. CVS Health has expected return of -0.1582%. Please be advised to confirm CVS Health Value At Risk as well as the relationship between Skewness and Day Median Price to decide if CVS Health past performance will be repeated at future time.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.28 

Poor predictability

CVS Health Corporation has poor predictability. Overlapping area represents the amount of predictability between CVS Health time series from February 27, 2017 to March 14, 2017 and March 14, 2017 to March 29, 2017. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CVS Health price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current CVS Health price fluctuation can be explain by its past prices.
Correlation Coefficient 0.28
Spearman Rank Test 0.43
Price Variance 0.27
Lagged Price Variance 0.16

CVS Health Lagged Returns

 Regressed Prices 
Benchmark  Embed    Timeline 

CVS Health Performance vs NYSE

The median price of CVS Health for the period between Mon, Feb 27, 2017 and Wed, Mar 29, 2017 is 80.42 with a coefficient of variation of 1.37. The daily time series for the period is distributed with a sample standard deviation of 1.09, arithmetic mean of 79.87, and mean deviation of 0.98. The Stock received some media coverage during the period.
Price Growth (%)  
Benchmark  Embed    Timeline